Bacterial Canine Vector-Borne Zoonotic Diseases in “One Health” Concept
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Distribution of Tick-Borne Diseases in China Xian-Bo Wu1, Ren-Hua Na2, Shan-Shan Wei2, Jin-Song Zhu3 and Hong-Juan Peng2*
Wu et al. Parasites & Vectors 2013, 6:119 http://www.parasitesandvectors.com/content/6/1/119 REVIEW Open Access Distribution of tick-borne diseases in China Xian-Bo Wu1, Ren-Hua Na2, Shan-Shan Wei2, Jin-Song Zhu3 and Hong-Juan Peng2* Abstract As an important contributor to vector-borne diseases in China, in recent years, tick-borne diseases have attracted much attention because of their increasing incidence and consequent significant harm to livestock and human health. The most commonly observed human tick-borne diseases in China include Lyme borreliosis (known as Lyme disease in China), tick-borne encephalitis (known as Forest encephalitis in China), Crimean-Congo hemorrhagic fever (known as Xinjiang hemorrhagic fever in China), Q-fever, tularemia and North-Asia tick-borne spotted fever. In recent years, some emerging tick-borne diseases, such as human monocytic ehrlichiosis, human granulocytic anaplasmosis, and a novel bunyavirus infection, have been reported frequently in China. Other tick-borne diseases that are not as frequently reported in China include Colorado fever, oriental spotted fever and piroplasmosis. Detailed information regarding the history, characteristics, and current epidemic status of these human tick-borne diseases in China will be reviewed in this paper. It is clear that greater efforts in government management and research are required for the prevention, control, diagnosis, and treatment of tick-borne diseases, as well as for the control of ticks, in order to decrease the tick-borne disease burden in China. Keywords: Ticks, Tick-borne diseases, Epidemic, China Review (Table 1) [2,4]. Continuous reports of emerging tick-borne Ticks can carry and transmit viruses, bacteria, rickettsia, disease cases in Shandong, Henan, Hebei, Anhui, and spirochetes, protozoans, Chlamydia, Mycoplasma,Bartonia other provinces demonstrate the rise of these diseases bodies, and nematodes [1,2]. -
Parinaud's Oculoglandular Syndrome
Tropical Medicine and Infectious Disease Case Report Parinaud’s Oculoglandular Syndrome: A Case in an Adult with Flea-Borne Typhus and a Review M. Kevin Dixon 1, Christopher L. Dayton 2 and Gregory M. Anstead 3,4,* 1 Baylor Scott & White Clinic, 800 Scott & White Drive, College Station, TX 77845, USA; [email protected] 2 Division of Critical Care, Department of Medicine, University of Texas Health, San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA; [email protected] 3 Medical Service, South Texas Veterans Health Care System, San Antonio, TX 78229, USA 4 Division of Infectious Diseases, Department of Medicine, University of Texas Health, San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA * Correspondence: [email protected]; Tel.: +1-210-567-4666; Fax: +1-210-567-4670 Received: 7 June 2020; Accepted: 24 July 2020; Published: 29 July 2020 Abstract: Parinaud’s oculoglandular syndrome (POGS) is defined as unilateral granulomatous conjunctivitis and facial lymphadenopathy. The aims of the current study are to describe a case of POGS with uveitis due to flea-borne typhus (FBT) and to present a diagnostic and therapeutic approach to POGS. The patient, a 38-year old man, presented with persistent unilateral eye pain, fever, rash, preauricular and submandibular lymphadenopathy, and laboratory findings of FBT: hyponatremia, elevated transaminase and lactate dehydrogenase levels, thrombocytopenia, and hypoalbuminemia. His condition rapidly improved after starting doxycycline. Soon after hospitalization, he was diagnosed with uveitis, which responded to topical prednisolone. To derive a diagnostic and empiric therapeutic approach to POGS, we reviewed the cases of POGS from its various causes since 1976 to discern epidemiologic clues and determine successful diagnostic techniques and therapies; we found multiple cases due to cat scratch disease (CSD; due to Bartonella henselae) (twelve), tularemia (ten), sporotrichosis (three), Rickettsia conorii (three), R. -
Q Fever in Small Ruminants and Its Public Health Importance
Journal of Dairy & Veterinary Sciences ISSN: 2573-2196 Review Article Dairy and Vet Sci J Volume 9 Issue 1 - January 2019 Copyright © All rights are reserved by Tolera Tagesu Tucho DOI: 10.19080/JDVS.2019.09.555752 Q Fever in Small Ruminants and its Public Health Importance Tolera Tagesu* School of Veterinary Medicine, Jimma University, Ethiopia Submission: December 01, 2018; Published: January 11, 2019 *Corresponding author: Tolera Tagesu Tucho, School of Veterinary Medicine, Jimma University, Jimma Oromia, Ethiopia Abstract Query fever is caused by Coxiella burnetii, it’s a worldwide zoonotic infectious disease where domestic small ruminants are the main reservoirs for human infections. Coxiella burnetii, is a Gram-negative obligate intracellular bacterium, adapted to thrive within the phagolysosome of the phagocyte. Humans become infected primarily by inhaling aerosols that are contaminated with C. burnetii. Ingestion (particularly drinking raw milk) and person-to-person transmission are minor routes. Animals shed the bacterium in urine and feces, and in very high concentrations in birth by-products. The bacterium persists in the environment in a resistant spore-like form which may become airborne and transported long distances by the wind. It is considered primarily as occupational disease of workers in close contact with farm animals or processing their be commenced immediately whenever Q fever is suspected. To prevent both the introduction and spread of Q fever infection, preventive measures shouldproducts, be however,implemented it may including occur also immunization in persons without with currently direct contact. available Doxycycline vaccines drugof domestic is the first small line ruminant of treatment animals for Q and fever. -
Coxiella Burnetii
SENTINEL LEVEL CLINICAL LABORATORY GUIDELINES FOR SUSPECTED AGENTS OF BIOTERRORISM AND EMERGING INFECTIOUS DISEASES Coxiella burnetii American Society for Microbiology (ASM) Revised March 2016 For latest revision, see web site below: https://www.asm.org/Articles/Policy/Laboratory-Response-Network-LRN-Sentinel-Level-C ASM Subject Matter Expert: David Welch, Ph.D. Medical Microbiology Consulting Dallas, TX [email protected] ASM Sentinel Laboratory Protocol Working Group APHL Advisory Committee Vickie Baselski, Ph.D. Barbara Robinson-Dunn, Ph.D. Patricia Blevins, MPH University of Tennessee at Department of Clinical San Antonio Metro Health Memphis Pathology District Laboratory Memphis, TN Beaumont Health System [email protected] [email protected] Royal Oak, MI BRobinson- Erin Bowles David Craft, Ph.D. [email protected] Wisconsin State Laboratory of Penn State Milton S. Hershey Hygiene Medical Center Michael A. Saubolle, Ph.D. [email protected] Hershey, PA Banner Health System [email protected] Phoenix, AZ Christopher Chadwick, MS [email protected] Association of Public Health Peter H. Gilligan, Ph.D. m Laboratories University of North Carolina [email protected] Hospitals/ Susan L. Shiflett Clinical Microbiology and Michigan Department of Mary DeMartino, BS, Immunology Labs Community Health MT(ASCP)SM Chapel Hill, NC Lansing, MI State Hygienic Laboratory at the [email protected] [email protected] University of Iowa [email protected] Larry Gray, Ph.D. Alice Weissfeld, Ph.D. TriHealth Laboratories and Microbiology Specialists Inc. Harvey Holmes, PhD University of Cincinnati College Houston, TX Centers for Disease Control and of Medicine [email protected] Prevention Cincinnati, OH om [email protected] [email protected] David Welch, Ph.D. -
CD Alert Monthly Newsletter of National Centre for Disease Control, Directorate General of Health Services, Government of India
CD Alert Monthly Newsletter of National Centre for Disease Control, Directorate General of Health Services, Government of India May - July 2009 Vol. 13 : No. 1 SCRUB TYPHUS & OTHER RICKETTSIOSES it lacks lipopolysaccharide and peptidoglycan RICKETTSIAL DISEASES and does not have an outer slime layer. It is These are the diseases caused by rickettsiae endowed with a major surface protein (56kDa) which are small, gram negative bacilli adapted and some minor surface protein (110, 80, 46, to obligate intracellular parasitism, and 43, 39, 35, 25 and 25kDa). There are transmitted by arthropod vectors. These considerable differences in virulence and organisms are primarily parasites of arthropods antigen composition among individual strains such as lice, fleas, ticks and mites, in which of O.tsutsugamushi. O.tsutsugamushi has they are found in the alimentary canal. In many serotypes (Karp, Gillian, Kato and vertebrates, including humans, they infect the Kawazaki). vascular endothelium and reticuloendothelial GLOBAL SCENARIO cells. Commonly known rickettsial disease is Scrub Typhus. Geographic distribution of the disease occurs within an area of about 13 million km2 including- The family Rickettsiaeceae currently comprises Afghanistan and Pakistan to the west; Russia of three genera – Rickettsia, Orientia and to the north; Korea and Japan to the northeast; Ehrlichia which appear to have descended Indonesia, Papua New Guinea, and northern from a common ancestor. Former members Australia to the south; and some smaller of the family, Coxiella burnetii, which causes islands in the western Pacific. It was Q fever and Rochalimaea quintana causing first observed in Japan where it was found to trench fever have been excluded because the be transmitted by mites. -
CASE REPORT the PATIENT 33-Year-Old Woman
CASE REPORT THE PATIENT 33-year-old woman SIGNS & SYMPTOMS – 6-day history of fever Katherine Lazet, DO; – Groin pain and swelling Stephanie Rutterbush, MD – Recent hiking trip in St. Vincent Ascension Colorado Health, Evansville, Ind (Dr. Lazet); Munson Healthcare Ostego Memorial Hospital, Lewiston, Mich (Dr. Rutterbush) [email protected] The authors reported no potential conflict of interest THE CASE relevant to this article. A 33-year-old Caucasian woman presented to the emergency department with a 6-day his- tory of fever (103°-104°F) and right groin pain and swelling. Associated symptoms included headache, diarrhea, malaise, weakness, nausea, cough, and anorexia. Upon presentation, she admitted to a recent hike on a bubonic plague–endemic trail in Colorado. Her vital signs were unremarkable, and the physical examination demonstrated normal findings except for tender, erythematous, nonfluctuant right inguinal lymphadenopathy. The patient was admitted for intractable pain and fever and started on intravenous cefoxitin 2 g IV every 8 hours and oral doxycycline 100 mg every 12 hours for pelvic inflammatory disease vs tick- or flea-borne illness. Due to the patient’s recent trip to a plague-infested area, our suspicion for Yersinia pestis infection was high. The patient’s work-up included a nega- tive pregnancy test and urinalysis. A com- FIGURE 1 plete blood count demonstrated a white CT scan from admission blood cell count of 8.6 (4.3-10.5) × 103/UL was revealing with a 3+ left shift and a platelet count of 112 (180-500) × 103/UL. A complete metabolic panel showed hypokalemia and hyponatremia (potassium 2.8 [3.5-5.1] mmol/L and sodium 134 [137-145] mmol/L). -
Protecting Yourself from Zoonotic Infection
PROTECTING YOURSELF FROM ZOONOTIC INFECTION What is a Zoonoses? A zoonotic disease is an infection that is naturally transmitted from vertebrate animals to human beings. Many of these infections are transmitted directly but others are passed via vectors such as mosquitoes or fleas. Not all animal diseases are zoonotic and far more human illnesses result from contact with other humans than from animals. However, it is important for anyone working with animals to be aware of the potential for infection and takes steps to prevent exposure. The following lists some of the more common or severe zoonoses and ways to help protect yourself and others from exposure. IMPORTANT RULES TO HELP YOU AVOID DEVELOPING A SERIOUS ZOONOTIC ILLNESS: Stay current on appropriate vaccinations, such as tetanus and rabies. Wash your hands frequently with antibacterial soap, especially after handling any animal and prior to eating or smoking. Wear long pants and sturdy shoes or boots. Use gloves when handling animals and when cleaning up feces, urine, or vomit. Immediately disinfect scratches and bite wounds thoroughly. Keep scratches or other abrasions covered, especially when cleaning up after animals. Learn safe and humane animal-handling techniques and use proper equipment. Seek assistance when handling animals whose dispositions are questionable. If exposed to tick-infested areas, check your body and clothing frequently. Use tweezers and wear gloves to remove ticks, taking care not to squeeze or puncture the body of the tick. Report any bites or injuries to a supervisor and seek medical treatment as appropriate. Tell your physician that you work closely with animals, and visit him or her regularly. -
Bartonella Henselae and Coxiella Burnetii Infection and the Kawasaki Disease
GALLEY PROOF J. Appl. Sci. Environ. Mgt. 2004 JASEM ISSN 1119-8362 Available Online at All rights reserved http:// www.bioline.org.br/ja Vol. 8 (1) 11 - 12 Bartonella henselae and Coxiella burnetii Infection and the Kawasaki Disease KEI NUMAZAKI, M D Department of Pediatrics, Sapporo Medical University School of Medicine, S.1 W.16 Chuo-ku Sapporo, 060-8543 Japan Phone: +81-611-2111 X3413 Fax: +81-611-0352 E-mail: [email protected] ABSTRACT: It was reported that Bartonella henselae, B. quintana and Coxiella burnetii was not strongly associated with coronary artery disease but on the basis of geometric mean titer, C. burnetii infection might have a modest association with coronary artery disease. Serum antibodies to B. henselae from 14 patients with acute phase of Kawasaki disease were determined by the indirect fluorescence antibody assay . Serum antibodies to C. burnetii were also tried to detect. However, no positive results were obtained. I also examined 10 children and 10 pregnant women who had serum IgG antibody to B. henselae or to C. burnetii. No one showed abnormal findings of coronary artery. @JASEM Several Bartonella species cause illness and associated with several infections, including asymptotic infection in humans. B. henselae has Chlamydia pneumoniae, cytomegalovirus, been associated with an increasing spectrum of Helicobacter pylori and other intercellular bacteria clinical syndromes including cat scratch disease. (Danesh et al., 1997). Previous studies supported Although the clinical spectrum has not been the possibility of certain populations having an completely clarified, B. quintana may cause association of infections and coronary artery disease blood-culture negative endocarditis in children Kawasaki disease (KD). -
WO 2013/042140 A4 28 March 2013 (28.03.2013) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/042140 A4 28 March 2013 (28.03.2013) P O P C T (51) International Patent Classification: NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, A61K 31/197 (2006.01) A61K 45/06 (2006.01) RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, A61K 31/60 (2006.01) A61P 31/00 (2006.01) TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, A61K 33/22 (2006.01) ZM, ZW. (21) International Application Number: (84) Designated States (unless otherwise indicated, for every PCT/IN20 12/000634 kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, (22) International Filing Date UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 24 September 2012 (24.09.2012) TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, (25) Filing Language: English EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (26) Publication Language: English TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, (30) Priority Data: ML, MR, NE, SN, TD, TG). 2792/DEL/201 1 23 September 201 1 (23.09.201 1) IN Declarations under Rule 4.17 : (72) Inventor; and — of inventorship (Rule 4.17(iv)) (71) Applicant : CHAUDHARY, Manu [IN/IN]; 51-52, In dustrial Area Phase- 1, Panchkula 1341 13 (IN). -
What Do We Know About Q Fever in Mexico?
ARTÍCULO ORIGINAL What do we know about Q fever in Mexico? Javier Araujo-Meléndez,* José Sifuentes-Osornio,* J. Miriam Bobadilla-del-Valle,* Antonio Aguilar-Cruz,** Orestes Torres-Ángeles,** José L. Ramírez-González,*** Alfredo Ponce-de-León,* Guillermo M. Ruiz-Palacios,* M. Lourdes Guerrero-Almeida* * Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. ** Jurisdicción Sanitaria No. 4, Huichapan, Hidalgo. *** Hospital General, Huichapan, Hidalgo. ABSTRACT ¿Qué sabemos acerca de la fiebre Q en México? In Mexico, Q fever is considered a rare disease among hu- RESUMEN mans and animals. From March to May of 2008, three pa- tients were referred, from the state of Hidalgo to a En México la fiebre Q se considera una enfermedad rara en- tertiary-care center in Mexico City, with an acute febrile ill- tre los humanos y los animales. Sin embargo, entre marzo y ness that was diagnosed as Q fever. We decided to undertake a mayo 2008 tres pacientes del estado de Hidalgo fueron refe- cross sectional pilot study to identify cases of acute disease in ridos a un hospital de tercer nivel en la Ciudad de México this particular region and to determine the seroprevalence of por una enfermedad febril aguda y fueron diagnosticados Coxiella burnetii among healthy individuals with known risk con fiebre Q. Se decidió llevar a cabo un estudio piloto para factors for infection with this bacteria. Q fever was defined identificar casos de enfermedad aguda en esa región y deter- according to the Centers for Disease Control and Prevention minar la prevalencia serológica de Coxiella burnetii en indi- criteria. -
Vectra® for Cats & Kittens and Vectra® for Cats
This is love. Wrapped in fur. Protect the love. FLEA CONTROL Facts About Fleas Can jump up to Can lay eggs 13” 24 hours after biting Females can lay 50 eggs per day Transmit and cause diseases like: Flea Allergy Dermatitis Tapeworm disease Bartonella Life cycle can be completed in Anemia (severe infestations) Feline Infectious Anemia 3 weeks Bubonic Plague Why are flea infestations so hard to get rid of? ONLY 5% OF THE FLEAS IN YOUR CAT’S ENVIRONMENT ARE ADULTS THAT BITE YOUR CAT. The remaining 95% are in the development stage ready to become adults within 3 weeks. 5% Adults 35% Larvae 50% Eggs 10% Pupae Vectra® for Cats & Kittens and Vectra® for Cats Vectra® for Cats & Kittens AND Vectra® for Cats protect your favorite feline from all stages of fleas. Applying Vectra® every month helps prevent flea infestation, re-infestation, and protects your cat or kitten from flea-borne diseases. Fast-Acting • Kills through contact so fleas do not have to bite in order to die • Protects cats and kittens against flea-borne diseases, including tularemia, rickettsiosis, Life cycle can be completed in bartonellosis, and tapeworm Flea Protection • Kills fleas at all life stages for 1 month • Adults • Eggs • Larvae • Pupae • Remains effective after exposure to sunlight Convenient • Patented applicator makes application easy, clean, and accurate • Can be used on kittens as young as 8 weeks of age How to apply Vectra® for Cats & Kittens and Vectra® for Cats Before administering Vectra® for the first time, you should ask your veterinarian to demonstrate the proper application technique. -
Tick-Borne Disease Working Group 2020 Report to Congress
2nd Report Supported by the U.S. Department of Health and Human Services • Office of the Assistant Secretary for Health Tick-Borne Disease Working Group 2020 Report to Congress Information and opinions in this report do not necessarily reflect the opinions of each member of the Working Group, the U.S. Department of Health and Human Services, or any other component of the Federal government. Table of Contents Executive Summary . .1 Chapter 4: Clinical Manifestations, Appendices . 114 Diagnosis, and Diagnostics . 28 Chapter 1: Background . 4 Appendix A. Tick-Borne Disease Congressional Action ................. 8 Chapter 5: Causes, Pathogenesis, Working Group .....................114 and Pathophysiology . 44 The Tick-Borne Disease Working Group . 8 Appendix B. Tick-Borne Disease Working Chapter 6: Treatment . 51 Group Subcommittees ...............117 Second Report: Focus and Structure . 8 Chapter 7: Clinician and Public Appendix C. Acronyms and Abbreviations 126 Chapter 2: Methods of the Education, Patient Access Working Group . .10 to Care . 59 Appendix D. 21st Century Cures Act ...128 Topic Development Briefs ............ 10 Chapter 8: Epidemiology and Appendix E. Working Group Charter. .131 Surveillance . 84 Subcommittees ..................... 10 Chapter 9: Federal Inventory . 93 Appendix F. Federal Inventory Survey . 136 Federal Inventory ....................11 Chapter 10: Public Input . 98 Appendix G. References .............149 Minority Responses ................. 13 Chapter 11: Looking Forward . .103 Chapter 3: Tick Biology, Conclusion . 112 Ecology, and Control . .14 Contributions U.S. Department of Health and Human Services James J. Berger, MS, MT(ASCP), SBB B. Kaye Hayes, MPA Working Group Members David Hughes Walker, MD (Co-Chair) Adalbeto Pérez de León, DVM, MS, PhD Leigh Ann Soltysiak, MS (Co-Chair) Kevin R.